tiprankstipranks
Medicinova (MNOV)
NASDAQ:MNOV
US Market

Medicinova (MNOV) Stock Forecast & Price Target

Compare
299 Followers
See the Price Targets and Ratings of:

MNOV Financial Forecast

MNOV Earnings Forecast

Next quarter’s earnings estimate for MNOV is -$0.07 with a range of -$0.07 to -$0.07. The previous quarter’s EPS was -$0.15. MNOV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.53% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.
Next quarter’s earnings estimate for MNOV is -$0.07 with a range of -$0.07 to -$0.07. The previous quarter’s EPS was -$0.15. MNOV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.53% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.

MNOV Sales Forecast

Next quarter’s sales forecast for MNOV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNOV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.
Next quarter’s sales forecast for MNOV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. MNOV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year MNOV has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
D. Boral Capital
$9
Buy
520.69%
Upside
Initiated
12/02/24
MediciNova initiated with a Buy at D. Boral CapitalMediciNova initiated with a Buy at D. Boral Capital
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
D. Boral Capital
$9
Buy
520.69%
Upside
Initiated
12/02/24
MediciNova initiated with a Buy at D. Boral CapitalMediciNova initiated with a Buy at D. Boral Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MNOV Analyst Recommendation Trends

Rating
Apr 22
Jun 22
Nov 22
Dec 22
Dec 24
Strong Buy
4
5
3
3
2
Buy
0
0
0
0
0
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
4
4
3
In the current month, MNOV has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MNOV average Analyst price target in the past 3 months is $9.00.
Each month's total comprises the sum of three months' worth of ratings.

MNOV Stock Forecast FAQ

What is MNOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Medicinova’s 12-month average price target is $9.00.
    What is MNOV’s upside potential, based on the analysts’ average price target?
    Medicinova has 520.69% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MNOV a Buy, Sell or Hold?
          Medicinova has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Medicinova’s price target?
            The average price target for Medicinova is $9.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 520.69% Increase from the current price of $1.45.
              What do analysts say about Medicinova?
              Medicinova’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of MNOV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis